Acumulado Enero - Diciembre 2023 (93 - 96) 93
ISSN 1317-987X
 
Buscar




Artículos
 



Asociación Venezolana para el Avance de la Ciencia
Variabilidad genética del hospedero y COVID-19

Referencias

  1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.
  2. Russell SL, Klaver BRA, Harrigan SP, Kamelian K, Tyson J, Hoang L, Taylor M, Sander B, Mishra S, Prystajecky N, Janjua NZ, Zlosnik JEA SH. Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population-based cohort study in British Columbia, Canada. J Med Virol. 2023;95(e28423). . doi: 10.1002/jmv.28423
  3. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271-280.e8.
  4. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383:1522–34.
  5. Zeberg H, Pääbo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020;587(7835):610–2. http://dx.doi.org/10.1038/s41586-020-2818-3
  6. Shelton JF, Shastri AJ, Ye C, Weldon CH, Filshtein-Sonmez T, Coker D, et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat Genet. 2021;53:801–8.
  7. Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591(7848):92–8.
  8. Wu SC, Arthur CM, Wang J, Verkerke H, Josephson CD, Kalman D, et al. The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A. Blood Adv. 2021;5:1305–9.
  9. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28:801–70.
  10. Galeev A, Suwandi A, Cepic A, Basu M, Baines JF, Grassl GA. The role of the blood group-related glycosyltransferases FUT2 and B4GALNT2 in susceptibility to infectious disease. Int J Med Microbiol. 2021;311:151487. doi: 10.1016/j.ijmm.2021.151487
  11. Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, et al. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group. Vox Sang. 2021;116:849–61.
  12. Soares DMB, Araújo DABS, de Souza JLB, Maurício RB, Soares EMB, Neto FCA, Pinheiro MSN, Gama VCV, Braga-Neto P, Nóbrega PR, Aragão GF. Correlation between ABO blood type, susceptibility to SARS-CoV-2 infection and COVID-19 disease severity: A systematic review. Hematol Transfus Cell Ther. 2022;30. doi: 10.1016/j.htct.2022.11.001.
  13. Cheng Y, Cheng G, Chui CH, Lau FY, Chan PKS, Ng MHL, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA [Internet]. 2005; 293:1450–1. doi: 10.1001/jama.293.12.1450-c.https://pubmed.ncbi.nlm.nih.gov/15784866/
  14. Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O'Farrelly C, Novelli G, Rodríguez-Gallego C, Haerynck F, Prando C, Pujol A; COVID Human Genetic Effort; Su HC, Casanova JL, Spaan AN. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nat Immunol. 2022;23:159-164. doi: 10.1038/s41590-021-01030-z
  15. Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics. 2020;14:1–8. doi: 10.1186/s40246-020-00290-4.
  16. Minashkin MM, Grigortsevich NY, Kamaeva AS, Barzanova V V., Traspov AA, Godkov MA, et al. The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and Outcomes. Biomedicines. 2022;10:549. doi: 10.3390/biomedicines10030549..
  17. Hummel S, Schmidt D, Kahle M, Herrmann B. ABO blood group genotyping of ancient DNA by PCR-RFLP. Int J Legal Med. 2002;116:327–33.
  18. Serpa J, Mendes N, Reis CA, Santos Silva LF, Almeida R, Le Pendu J, et al. Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G→A and 839T→C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal. Biochem J. 2004;383:469–74.

Variabilidad genética del hospedero y COVID-19
Fundamentos
Genes candidatos
Infección por SARS-CoV-2 y grupo ABO
Resultados experimentales
Conclusión
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit